News

Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...
Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...
When it came to cardiovascular incidents, the report showed major gains for GLP-1 users, too. 44% experienced fewer ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
TikTok creator Janelle Rohner revealed she is taking a GLP-1 medication for weight loss — despite selling $200 courses to ...
The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.
While these medications offer unprecedented health benefits, they come with challenges like cost, non-adherence and lack of ...
Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.
The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...
High-street pharmacies are ready to provide the jabs on the NHS and boost take-up for all, says senior pharmacist ...
Full Frame Growth Partners is a minority investor in California-based Supergut, a company making powdered supplements and ...